James E Fickenscher Insider Trading $ZYNE Zynerba Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James E Fickenscher.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E Fickenscher. James E Fickenscher is Senior Vice President & CFO in ANTARES PHARMA, INC. ($ATRS) and Chief Financial Officer in AUXILIUM PHARMACEUTICALS INC ($AUXL) and Chief Financial Officer in Zynerba Pharmaceuticals, Inc. ($ZYNE).
James E Fickenscher in Zynerba Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Fickenscher: Chief Financial Officer
Holdings: 72,718 shares
Current Value: $1,343,101
Latest Transaction: Jan 25 2021
$ZYNE Market Capitalization: $186.92M
$ZYNE Previous Close: $18.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James E Fickenscher in Zynerba Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRS, AUXL, ZYNE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 3.58 | 78,000 | 279,240 | 78,000 | |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Grant | A | 0.00 | 52,000 | 0 | 72,718 | 20.7 K to 72.7 K (+250.99 %) |
| Feb 03 2020 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 5.05 | 85,000 | 429,250 | 85,000 | |
| Jan 28 2019 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 3.65 | 88,099 | 321,561 | 88,099 | |
| Aug 07 2018 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Buy | P | 5.97 | 8,518 | 50,842 | 20,718 | 12.2 K to 20.7 K (+69.82 %) |
| Jan 16 2018 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 11.71 | 67,500 | 790,425 | 67,500 | |
| May 16 2017 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Buy | P | 19.82 | 5,200 | 103,064 | 12,200 | 7 K to 12.2 K (+74.29 %) |
| Jan 26 2017 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 18.22 | 31,350 | 571,197 | 31,350 | |
| Dec 08 2016 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Buy | P | 14.03 | 4,000 | 56,120 | 7,000 | 3 K to 7 K (+133.33 %) |
| Dec 08 2016 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Buy | P | 14.15 | 3,000 | 42,450 | 3,000 | 0 to 3 K |
| Sep 22 2016 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 10.23 | 150,000 | 1,534,500 | 150,000 |
Page: 1